Skip to content
Rare blood cancer drug wins FDA approval
The U.S. Food and Drug Administration (FDA) has approved TIBSOVO (ivosidenib) as a treatment for a rare blood cancer, the agency said in an […]
Rare blood cancer drug wins FDA approval Read More »
Health
Turning insights into action: building a U.S. health system that delivers for all women
Dr. Mary-Ann Etiebet, Associate Vice President, Health Equity, Merck, has more than two decades of experience working across the public and private sectors to
Turning insights into action: building a U.S. health system that delivers for all women Read More »
A new class of medicines provides hope for patients at risk of dangerous blood clots
Blood clots are commonly missed. According to the National Blood Clot Alliance (NBCA), “fewer than 1 in 4 people have any recognition of blood
A new class of medicines provides hope for patients at risk of dangerous blood clots Read More »
Patients are your best advocates – here’s how to support them
Patients’ stories are powerful—especially when it comes to advocacy, agreed panelists at the Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit. An October
Patients are your best advocates – here’s how to support them Read More »
How COVID-19 is increasing incidence of another life-threatening condition
Sepsis is the third most common cause of disease-related death in the United States. Bacterial infections are the most common cause of sepsis. But
How COVID-19 is increasing incidence of another life-threatening condition Read More »
How to protect patient access to Medicaid
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during
How to protect patient access to Medicaid Read More »
Why patient advocacy is ‘at the heart’ of biotech sector’s work
“Patient advocacy is at heart of what BIO is working to accomplish within this community to extend the lives of patients,” said Rachel King,
Why patient advocacy is ‘at the heart’ of biotech sector’s work Read More »
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs
“The Inflation Reduction Act (IRA) was one of President Biden’s signature achievements and will help many Americans,” began Christina Hochul of Alexion Pharmaceuticals, Inc.,
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs Read More »
What we’re watching at the 2023 Patient & Health Advocacy Summit
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit is kicking off in Washington, D.C. Now in its 12th year, the event brings
What we’re watching at the 2023 Patient & Health Advocacy Summit Read More »
FTC plans for aggressive merger enforcement threaten biotech innovation, BIO says
Federal Trade Commission (FTC) proposals for new rules to permit more aggressive opposition to mergers would interfere with the economic ecosystem that is essential
FTC plans for aggressive merger enforcement threaten biotech innovation, BIO says Read More »